双(2-氯乙基)甲胺 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "双(2-氯乙基)甲胺" in Chinese language version.

refsWebsite

Global rank Chinese rank

12doi.org

2^nd place

23^rd place

10nih.gov

4^th place

5^th place

9web.archive.org

1^st place

3archive.org

6^th place

4^th place

2drugs.com

399^th place

208^th place

2fda.gov

447^th place

581^st place

1tga.gov.au

3,984^th place

1,603^rd place

1europa.eu

68^th place

209^th place

1cancernetwork.com

low place

7,315^th place

1cdc.gov

218^th place

198^th place

1semanticscholar.org

11^th place

332^nd place

1europepmc.org

8,929^th place

6,275^th place

1harvard.edu

18^th place

57^th place

archive.org

McErlane, KM; Wood, RJ; Matsui, F; Lovering, EG. Impurities in Drugs II: Meperidine and Its Formulations. Journal of Pharmaceutical Sciences. July 1978, 67 (7): 958–961. PMID 660515. doi:10.1002/jps.2600670723.
Gilman, Alfred. The initial clinical trial of nitrogen mustard. Am J Surg. 1963, 105 (5): 574–578. PMID 13947966. doi:10.1016/0002-9610(63)90232-0.
Fenn, John E.; et al. First Use of Intravenous Chemotherapy Cancer Treatment: Rectifying the Record. Journal of the American College of Surgeons. 2011, 212 (3): 413–417. PMID 21247779. doi:10.1016/j.jamcollsurg.2010.10.018.

cancernetwork.com

Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" （页面存档备份，存于互联网档案馆） in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach （页面存档备份，存于互联网档案馆）. 11 ed. 2008.

cdc.gov

CDC - The Emergency Response Safety and Health Database: Blister Agent: NITROGEN MUSTARD HN-2 - NIOSH. www.cdc.gov. [2016-04-20]. （原始内容存档于2019-06-28）.

doi.org

Rappeneau S, Baeza-Squiban A, Jeulin C, Marano F. Protection from cytotoxic effects induced by the nitrogen mustard mechlorethamine on human bronchial epithelial cells in vitro. Toxicol. Sci. March 2000, 54 (1): 212–21. PMID 10746948. doi:10.1093/toxsci/54.1.212 .
Bunn Jr, P. A.; Hoffman, S. J.; Norris, D; Golitz, L. E.; Aeling, J. L. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Annals of Internal Medicine. 1994, 121 (8): 592–602. PMID 8085692. S2CID 22909007. doi:10.7326/0003-4819-121-8-199410150-00007.
McErlane, KM; Wood, RJ; Matsui, F; Lovering, EG. Impurities in Drugs II: Meperidine and Its Formulations. Journal of Pharmaceutical Sciences. July 1978, 67 (7): 958–961. PMID 660515. doi:10.1002/jps.2600670723.
Krumbhaar EB, Krumbhaar HD. The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases. J Med Res. 1919, 40 (5): 497–508 [2022-02-25]. PMID 13947966. doi:10.1016/0002-9610(63)90232-0. （原始内容存档于2020-02-10）.
Ward, Kyle. The Chlorinated Ethylamines — A New Type of Vesicant. J. Am. Chem. Soc. 1935, 57 (5): 914–916. doi:10.1021/ja01308a041.
V. Prelog, V. Štěpán. Nouvele synthèse des pipérazines N-monoalcoylées (VIIième communication sur les bis-[β-halogénoéthyl]-amines). Collection of Czechoslovak Chemical Communications. 1935, 7: 93–102. doi:10.1135/cccc19350093.
Berenblum I. Experimental inhibition of tumor induction by mustard gas and other compounds. Journal of Pathology and Bacteriology. 1935, 40 (3): 549–558. doi:10.1002/path.1700400312.
Einhorn, J. Nitrogen mustard: the origin of chemotherapy for cancer. Int J Radiat Oncol Biol Phys. 1985, 11 (7): 1375–1378. PMID 3891698. doi:10.1016/0360-3016(85)90254-8.
Alfred Gilman, Frederick S. Philips. The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides. Science. 1946, 103 (2675): 409–436. Bibcode:1946Sci...103..409G. PMID 17751251. doi:10.1126/science.103.2675.409.
Gilman, Alfred. The initial clinical trial of nitrogen mustard. Am J Surg. 1963, 105 (5): 574–578. PMID 13947966. doi:10.1016/0002-9610(63)90232-0.
Fenn, John E.; et al. First Use of Intravenous Chemotherapy Cancer Treatment: Rectifying the Record. Journal of the American College of Surgeons. 2011, 212 (3): 413–417. PMID 21247779. doi:10.1016/j.jamcollsurg.2010.10.018.
Jacobson L.O., Spurr C.L., Barron E., Smith T., Lushbaugh C., Dick G.F. Nitrogen Mustard Therapy: Studies on the Effect of Methyl-Bis (Beta-Chloroethyl) Amine Hydrochloride on Neoplastic Diseases and Allied Disorders of the Hemopoietic System. JAMA. 1946, 132 (2675): 263–271. PMID 20997209. doi:10.1001/jama.1946.02870400011003.

drugs.com

Recordati Rare Diseases Inc. (2013). Mustargen Package Insert. Retrieved from https://www.drugs.com/pro/mustargen.html （页面存档备份，存于互联网档案馆）
Mustargen （页面存档备份，存于互联网档案馆） and Valchlor （页面存档备份，存于互联网档案馆）

europa.eu

ema.europa.eu

Ledaga EPAR. European Medicines Agency. 17 September 2018 [5 September 2021]. （原始内容存档于2021-09-05）.

europepmc.org

Krumbhaar EB, Krumbhaar HD. The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases. J Med Res. 1919, 40 (5): 497–508 [2022-02-25]. PMID 13947966. doi:10.1016/0002-9610(63)90232-0. （原始内容存档于2020-02-10）.

fda.gov

accessdata.fda.gov

Actelion Pharmaceuticals Ltd. (2013) Valchlor Package Insert. Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202317lbl.pdf （页面存档备份，存于互联网档案馆）
Mustargen （页面存档备份，存于互联网档案馆） and Valchlor （页面存档备份，存于互联网档案馆）

harvard.edu

ui.adsabs.harvard.edu

Alfred Gilman, Frederick S. Philips. The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides. Science. 1946, 103 (2675): 409–436. Bibcode:1946Sci...103..409G. PMID 17751251. doi:10.1126/science.103.2675.409.

nih.gov

ncbi.nlm.nih.gov

Rappeneau S, Baeza-Squiban A, Jeulin C, Marano F. Protection from cytotoxic effects induced by the nitrogen mustard mechlorethamine on human bronchial epithelial cells in vitro. Toxicol. Sci. March 2000, 54 (1): 212–21. PMID 10746948. doi:10.1093/toxsci/54.1.212 .
Bunn Jr, P. A.; Hoffman, S. J.; Norris, D; Golitz, L. E.; Aeling, J. L. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Annals of Internal Medicine. 1994, 121 (8): 592–602. PMID 8085692. S2CID 22909007. doi:10.7326/0003-4819-121-8-199410150-00007.
McErlane, KM; Wood, RJ; Matsui, F; Lovering, EG. Impurities in Drugs II: Meperidine and Its Formulations. Journal of Pharmaceutical Sciences. July 1978, 67 (7): 958–961. PMID 660515. doi:10.1002/jps.2600670723.
Krumbhaar EB, Krumbhaar HD. The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases. J Med Res. 1919, 40 (5): 497–508 [2022-02-25]. PMID 13947966. doi:10.1016/0002-9610(63)90232-0. （原始内容存档于2020-02-10）.
Einhorn, J. Nitrogen mustard: the origin of chemotherapy for cancer. Int J Radiat Oncol Biol Phys. 1985, 11 (7): 1375–1378. PMID 3891698. doi:10.1016/0360-3016(85)90254-8.
Alfred Gilman, Frederick S. Philips. The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides. Science. 1946, 103 (2675): 409–436. Bibcode:1946Sci...103..409G. PMID 17751251. doi:10.1126/science.103.2675.409.
Gilman, Alfred. The initial clinical trial of nitrogen mustard. Am J Surg. 1963, 105 (5): 574–578. PMID 13947966. doi:10.1016/0002-9610(63)90232-0.
Fenn, John E.; et al. First Use of Intravenous Chemotherapy Cancer Treatment: Rectifying the Record. Journal of the American College of Surgeons. 2011, 212 (3): 413–417. PMID 21247779. doi:10.1016/j.jamcollsurg.2010.10.018.
Jacobson L.O., Spurr C.L., Barron E., Smith T., Lushbaugh C., Dick G.F. Nitrogen Mustard Therapy: Studies on the Effect of Methyl-Bis (Beta-Chloroethyl) Amine Hydrochloride on Neoplastic Diseases and Allied Disorders of the Hemopoietic System. JAMA. 1946, 132 (2675): 263–271. PMID 20997209. doi:10.1001/jama.1946.02870400011003.

nlm.nih.gov

Medline (2012). Mechlorethamine. Retrieved from https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682223.html （页面存档备份，存于互联网档案馆）

semanticscholar.org

api.semanticscholar.org

Bunn Jr, P. A.; Hoffman, S. J.; Norris, D; Golitz, L. E.; Aeling, J. L. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Annals of Internal Medicine. 1994, 121 (8): 592–602. PMID 8085692. S2CID 22909007. doi:10.7326/0003-4819-121-8-199410150-00007.

tga.gov.au

Ledaga. Therapeutic Goods Administration (TGA). 30 June 2021 [5 September 2021]. （原始内容存档于2021-09-05）.

web.archive.org

Ledaga. Therapeutic Goods Administration (TGA). 30 June 2021 [5 September 2021]. （原始内容存档于2021-09-05）.
Ledaga EPAR. European Medicines Agency. 17 September 2018 [5 September 2021]. （原始内容存档于2021-09-05）.
Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" （页面存档备份，存于互联网档案馆） in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach （页面存档备份，存于互联网档案馆）. 11 ed. 2008.
CDC - The Emergency Response Safety and Health Database: Blister Agent: NITROGEN MUSTARD HN-2 - NIOSH. www.cdc.gov. [2016-04-20]. （原始内容存档于2019-06-28）.
Medline (2012). Mechlorethamine. Retrieved from https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682223.html （页面存档备份，存于互联网档案馆）
Recordati Rare Diseases Inc. (2013). Mustargen Package Insert. Retrieved from https://www.drugs.com/pro/mustargen.html （页面存档备份，存于互联网档案馆）
Actelion Pharmaceuticals Ltd. (2013) Valchlor Package Insert. Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202317lbl.pdf （页面存档备份，存于互联网档案馆）
Mustargen （页面存档备份，存于互联网档案馆） and Valchlor （页面存档备份，存于互联网档案馆）
Krumbhaar EB, Krumbhaar HD. The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases. J Med Res. 1919, 40 (5): 497–508 [2022-02-25]. PMID 13947966. doi:10.1016/0002-9610(63)90232-0. （原始内容存档于2020-02-10）.